NCT07145112View on ClinicalTrials.gov

Laser Interstitial Thermal Therapy (LITT) and Lomustine (CCNU) for Recurrent Glioblastoma

PHASE1RecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

October 1, 2025

Primary Completion Date

July 31, 2027

Study Completion Date

December 31, 2027

Conditions
Glioblastoma
Interventions
PROCEDURE

Laser interstitial thermal therapy

MRI guided laser

DRUG

Lomustine

Given orally (PO)

Trial Locations (1)

95827

RECRUITING

University of California Davis Comprehensive Cancer Center, Sacramento

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

University of California, Davis

OTHER